Physician profile
Jonathan D Lawless
NPI 1053677518
$287.26
in general payments reported to CMS, 2019-2025
9 companies · $23.48 in 2025
The $23.48 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.95 · 2020: $15.27 · 2021: $11.74 · 2022: $101 · 2023: $62.06 · 2024: $60.41 · 2025: $23.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $99.23 | 2023-2024 | |
| Amgen INC. | $41.98 | 2022-2025 | Krystexxa |
| Fidia Pharma USA INC. | $30.14 | 2021-2022 | |
| Abbott Laboratories | $27.12 | 2022 | |
| Incyte Corporation | $23.24 | 2023 | Opzelura |
| Lilly USA, LLC | $20.41 | 2022 | |
| Ucb, INC. | $16.92 | 2022 | |
| Dermira, INC. | $15.27 | 2020 | |
| Depuy Synthes Sales INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lawless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.